| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/04/2004 | US6730505 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/04/2004 | US6730500 Methods for generating a continuous nucleotide sequence from noncontiguous nucleotide sequences |
| 05/04/2004 | US6730499 Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1 |
| 05/04/2004 | US6730498 Production of functional proteins: balance of shear stress and gravity |
| 05/04/2004 | US6730491 Nucleotide sequences coding an enzymatic polypeptide for use in the treatment of cell proliferative or differentiative, nervous system, immune, cardiovascular, liver and skin disorders |
| 05/04/2004 | US6730489 Antibodies to truncated VEGF-D and uses thereof |
| 05/04/2004 | US6730488 Immunoassay for detecting preferential enzymatic polypeptide in sample |
| 05/04/2004 | US6730486 Human βTrCP protein |
| 05/04/2004 | US6730483 Phagemid for antibody screening |
| 05/04/2004 | US6730482 Modified SELEX processes without purified protein |
| 05/04/2004 | US6730481 Generation of adjusted nucleotide sequences; obtain nucleotide sequence mixture, incubate with modulator and enzyme, recover adjusted nucleotide sequence |
| 05/04/2004 | US6730480 Sphingosine kinase enzyme |
| 05/04/2004 | US6730479 Detection of nucleic acid hybrids |
| 05/04/2004 | US6730476 Methods of diagnosing early-onset menopause |
| 05/04/2004 | US6730474 By applying hybridization techniques that involve nucleic acid probes having both high sensitivity and specificity; genetic diagnosis in pathology and hematology |
| 05/04/2004 | US6730306 Plant antigens |
| 05/04/2004 | US6730303 Fused G-CSF and IL-3 proteins and uses thereof |
| 05/04/2004 | US6730302 Intracellular targeted delivery of compounds by 70 kD heat shock protein |
| 05/04/2004 | US6730301 Mediating chemotaxis and activation of monocytes; athero-sclerosis; monocyte chemoattractant protein-1 (mcp-1) |
| 05/04/2004 | US6730300 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 05/04/2004 | US6730297 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 05/04/2004 | US6730296 Receptor agonists and antagonists |
| 05/04/2004 | US6730208 Biological or chemical sensors; dna chips |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/04/2004 | CA2240296C Endothelial cell proliferation inhibitor and method of use |
| 05/04/2004 | CA2120137C Feline leukemia virus vaccines |
| 05/04/2004 | CA2110442C Process for obtaining proinsulin possessing correctly linked cystine bridges |
| 05/04/2004 | CA2082935C A method of enzyme production in trichoderma modified to be at least partially cellulase deficient |
| 05/04/2004 | CA2080226C Cd4-gamma2 and cd4-igg2 chimeras |
| 04/30/2004 | CA2446175A1 Micro/nano-structures fabricated by laser ablation for micro-array applications |
| 04/30/2004 | CA2444200A1 Microfluidic system for analyzing nucleic acids |
| 04/29/2004 | WO2004036219A1 Demethylated and/or oxidized membrane dna and use thereof in the diagnostic of autoimmune diseases |
| 04/29/2004 | WO2004036171A2 Disease detection by digital protein truncation assays |
| 04/29/2004 | WO2004035832A1 Method for detecting mutations |
| 04/29/2004 | WO2004035819A2 Oligonucleotide analogues for detecting and analyzing nucleic acids |
| 04/29/2004 | WO2004035806A2 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene |
| 04/29/2004 | WO2004035799A2 Viral vectors and the use of the same for gene therapy |
| 04/29/2004 | WO2004035798A2 Identification of e2f target genes and uses thereof |
| 04/29/2004 | WO2004035797A2 Tissue-specific promoters from plants |
| 04/29/2004 | WO2004035796A1 Expressional enhancers from viruses |
| 04/29/2004 | WO2004035795A1 Vector for anti-hpv vaccine and transformed microorganism by the vector |
| 04/29/2004 | WO2004035793A1 Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses thereof |
| 04/29/2004 | WO2004035792A1 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs |
| 04/29/2004 | WO2004035791A1 Plant alpha farnesene synthase and polynucleotides encoding same |
| 04/29/2004 | WO2004035790A1 Use of bifunctional alpha-amylase subtilisin inhibitor promoter to direct expression in the maternal tissue of a plant seed |
| 04/29/2004 | WO2004035789A1 Gene families associated with cancers |
| 04/29/2004 | WO2004035788A1 Novel genes and proteins encoded thereby |
| 04/29/2004 | WO2004035787A2 Transplantable cell with immune modulator |
| 04/29/2004 | WO2004035786A1 A method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase |
| 04/29/2004 | WO2004035784A2 Soluble rna polymerase protein and methods for the use thereof |
| 04/29/2004 | WO2004035782A2 Sirna mediated gene silencing in transgenic animals |
| 04/29/2004 | WO2004035781A1 Method for the manufacture of nucleic acid molecules |
| 04/29/2004 | WO2004035780A1 Gene expression vector using echinus-origin insulators |
| 04/29/2004 | WO2004035779A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/29/2004 | WO2004035778A1 Substrates specific to von willebrand factor cleaving protease and method of assaying the activity |
| 04/29/2004 | WO2004035777A1 Adipocyte differentiation-associated genes and proteins |
| 04/29/2004 | WO2004035776A1 Apparatus for introducing biological material, method of introducing biological material and magnetic support for introducing biological material |
| 04/29/2004 | WO2004035775A2 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 04/29/2004 | WO2004035774A2 Expression vectors for selection from stem cells of differentiated cardiomyocytes |
| 04/29/2004 | WO2004035772A1 Protein synthesis system using xenopus oocyte extract |
| 04/29/2004 | WO2004035771A1 Mutated nucleic acid of a cel i-endonuclease and method for producing the recombinant, full-length cel i-protein |
| 04/29/2004 | WO2004035769A1 Improved immunotherapy |
| 04/29/2004 | WO2004035765A2 Double-stranded rna structures and constructs, and methods for generating and using the same |
| 04/29/2004 | WO2004035763A2 Antisense modulation of gfat expression |
| 04/29/2004 | WO2004035760A2 Complete biosynthetic gene set for biosynthesis of albicidin, resistance genes, and uses thereof |
| 04/29/2004 | WO2004035759A2 Inhibitory oligonucleotides targeted to matrix metalloproteinase-9 |
| 04/29/2004 | WO2004035758A2 Rna-based inhibitory oligonucleotides |
| 04/29/2004 | WO2004035756A2 MODIFIED NUCLEOTIDE SEQUENCE ENCODING C. ALBICANS KiF1 KINESIN PROTEIN |
| 04/29/2004 | WO2004035755A2 Transporters and ion channels |
| 04/29/2004 | WO2004035750A2 Methods for accumulating translocated proteins |
| 04/29/2004 | WO2004035748A2 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 04/29/2004 | WO2004035743A2 Site specific incorporation of keto amino acids into proteins |
| 04/29/2004 | WO2004035735A2 A structured peptide scaffold for displaying turn libraries on phage |
| 04/29/2004 | WO2004035734A2 Plastid transformation |
| 04/29/2004 | WO2004035731A2 Increasing host plant susceptibility to agrobacterium infection by overexpression of the arabidopsis vip1 gene |
| 04/29/2004 | WO2004035676A2 Antisense modulation of notch (drosophila) homolog 4 expression |
| 04/29/2004 | WO2004035628A1 Regulation o-if the cre recombinase using a dissociation/re association system of said recombinase |
| 04/29/2004 | WO2004035626A2 Alpha macroglobulin protein family members |
| 04/29/2004 | WO2004035622A2 Antagonists il-15 |
| 04/29/2004 | WO2004035619A1 Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments |
| 04/29/2004 | WO2004035616A2 Adenovirus expressing genes in reverse order and use thereof |
| 04/29/2004 | WO2004035615A2 Factor involved in metastasis and uses thereof |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035609A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions. |
| 04/29/2004 | WO2004035088A1 Therapeutics/diagnostics for brain tumor |
| 04/29/2004 | WO2004035076A1 Treatment of tnf-alpha-mediated disorders with casein kinase i epsilon inhibitors |
| 04/29/2004 | WO2004035010A2 Methods and organisms for production of b6 vitamers |
| 04/29/2004 | WO2004035006A2 Methods and compositions for immunization against hiv |
| 04/29/2004 | WO2004034995A2 Methods and reagents for inducing immunity |
| 04/29/2004 | WO2004034956A2 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 04/29/2004 | WO2004034780A2 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 04/29/2004 | WO2004034778A2 Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same |
| 04/29/2004 | WO2004029256A3 Vector for the production of transplastomic angiosperm plants |
| 04/29/2004 | WO2004022782A3 Compositions and methods for tissue specific or inducible inhibition of gene expression |
| 04/29/2004 | WO2004020640A3 Zinc-regulated prokaryotic expression cassettes |
| 04/29/2004 | WO2004016151A3 Pthrp-derived modulators of smooth muscle proliferation |
| 04/29/2004 | WO2004015107A3 Further novel forms of interfering rna molecules |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2004011491A3 Peptidyl-trna hydrolase of enterococcus faecalis |
| 04/29/2004 | WO2004009810A3 Transgenic animal models of hrv with humani icam-1 sequences |